ClinicalTrials.Veeva

Menu

OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure

NHS Trust logo

NHS Trust

Status

Enrolling

Conditions

Hypertension

Treatments

Other: Kvatchii Portal

Study type

Interventional

Funder types

Other

Identifiers

NCT05575453
INGN21CA393

Details and patient eligibility

About

Hypertension is the leading modifiable risk factor for cardiovascular disease and is implicated in half of all strokes and myocardial infarctions. One-third of adults in Scotland have hypertension yet only one-quarter of these have their blood pressure (BP) controlled to target (<140/90 mmHg). Reasons for the low rate of control are varied but include individuals lack of confidence, knowledge and understanding of the condition and treatment strategy, non-adherence to medication and infrequent BP monitoring. These issues have been compounded by the ongoing COVID-19 pandemic which has brought changes in routine BP screening, access to medical care and chronic disease management in primary and secondary care, shielding of the highest risk groups and a change in health and research focus. Shared decision making and issues around health literacy were highlighted by the Scottish Government Cross Party Group on Heart Disease and Stroke: High Blood Pressure Task Force in 2019. Empowering patients to have a better understanding of their condition and becoming actively involved in the monitoring and management of hypertension may lead to improved patient satisfaction, improved BP control and health outcomes and reduction in the use of primary/secondary care hypertension clinics.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥18
  • Current attendance at the GBPC

Exclusion criteria

  • Inability to give informed consent
  • Non-English speakers
  • No internet access
  • Clinic or ambulatory blood pressure ≥180/120 mmHg
  • Arm circumference >42cm
  • Inability to perform HBPM
  • Inability to use Kvatchii portal
  • Pregnancy
  • Persistent atrial fibrillation
  • Acute cardiovascular event requiring hospitalisation in the previous 3 months
  • CKD stage ≥4 or renal dialysis
  • Severe or terminal illness limiting study participation

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

200 participants in 2 patient groups

Kvatchii Portal
Active Comparator group
Description:
The intervention group will be given access to the Kvatchii portal and home blood pressure monitor
Treatment:
Other: Kvatchii Portal
Usual Care
No Intervention group
Description:
The control group will not have access to the portal but will be provided with home blood pressure monitor

Trial contacts and locations

1

Loading...

Central trial contact

Linsay McCallum, MBChB PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems